April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Spectral-Domain OCT May Be Able to Detect Plaquenil Toxicity Before Symptomatic Vision Loss Occurs
Author Affiliations & Notes
  • J. C. Schell
    Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • K. E. Stepien
    Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • D. P. Han
    Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • J. Carroll
    Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • J. Rha
    Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • Footnotes
    Commercial Relationships  J.C. Schell, None; K.E. Stepien, None; D.P. Han, None; J. Carroll, None; J. Rha, None.
  • Footnotes
    Support  Research to Prevent Blindness Career Development Award, Fight for Sight, E. Matilda Ziegler Foundation for the Blind
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3266. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. C. Schell, K. E. Stepien, D. P. Han, J. Carroll, J. Rha; Spectral-Domain OCT May Be Able to Detect Plaquenil Toxicity Before Symptomatic Vision Loss Occurs. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3266.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe findings in Plaquenil toxicity as seen on Spectral- Domain OCT (SD-OCT) and Adaptive Optics (AO) imaging.

Methods: : Presentation of two patients with history of Plaquenil use for approximately 20 years. Both were found to have bilateral paracentral superotemporal visual field defects on 10-2 Humphery Visual Field (HVF) testing. Scans were obtained through the macula using the Spectralis SD-OCT (Heidelberg, Heidelberg Germany). Additional images in the parafoveal region were obtained with Adaptive Optics.

Results: : SD-OCT images demonstrated loss of photoreceptor inner segment/outer segment junction (IS/OS), thinning of the outer nuclear layer (ONL), and disruption of the outer retinal layers in areas corresponding to HVF defects and funduscopic findings. SD-OCT also showed isolated irregularities in IS/OS junction in areas not detected on HVF. AO imaging showed heterogeneity of the cone photoreceptor mosaic in the perifoveal area.

Conclusions: : SD-OCT shows loss of IS/OS junction and disruption of the outer retinal layers in areas of abnormalities demonstrated on 10-2 HVF. Additionally, IS/OS abnormalities are noted in areas that do not show HVF changes, likely indicating areas that are affected by toxicity but have not yet caused visual disturbances. SD-OCT may be able to detect changes in IS/OS junction in early Plaquenil toxicity before symptomatic damage and vision loss occur. AO imaging also shows changes in the cone mosaic in areas of toxicity and may be helpful in detecting toxicity at an earlier stage.

Keywords: imaging/image analysis: clinical • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×